XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Cash flows from operating activities    
Net loss $ (58,987) $ 128,121
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 3,643  
Amortization of intangible lease liabilities (371)  
Amortization of deferred financing costs (25)  
Paid in kind interest (1,016)  
Realized (gain)/loss (2,846) (30,434)
Net change in unrealized (gain) loss on investments held at fair value 78,238 (32,593)
Equity in losses of unconsolidated ventures 1,581  
Distributions of earnings from unconsolidated ventures 1,692  
Changes in operating assets and liabilities, net of effects of acquisitions:    
Operating assets (3,795)  
Operating liabilities 9,459  
Net cash provided by operating activities 27,573 37,623
Cash flows from investing activities    
Proceeds from asset redemptions 10,872  
Distributions from CLO investments 18,100  
Purchases of investments (9,925)  
Contributions to equity method investments (1,382)  
Additions to real estate investments (1,317)  
Acquisitions of real estate investments (26,500)  
Cash paid for life settlement premiums (3,022)  
Net cash used in investing activities (13,174)  
Cash flows from financing activities    
Proceeds received from notes payable 13,250  
Mortgage payments (591)  
Prime brokerage borrowing 2,567  
Credit facilities payments (9,500)  
Payment of costs associated with the Business Change (92)  
Deferred financing costs paid (379)  
Dividends paid to preferred shareholders (1,155)  
Dividends paid to common shareholders (5,577)  
Net cash used in financing activities (1,477) (36,258)
Net increase in cash, cash equivalents and restricted cash 12,922 1,365
Cash, cash equivalents and restricted cash, beginning of period (Note 3) 4,044 2,679
Cash, cash equivalents and restricted cash, end of period 63,698 4,044
Supplemental Disclosure of Cash Flow Information    
Interest paid (2,722) (614)
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]    
Cash flows from financing activities    
Cash, cash equivalents and restricted cash, beginning of period (Note 3) $ 50,776  
Cash, cash equivalents and restricted cash, end of period   $ 50,776